Both in vitro and in vivo experiments have demonstrated that knocking down NFE2L3 leads to a reduction in the proliferation of colon cancer cells, thereby inhibiting tumor growth (Chowdhury et al., 2017; Bury et al., 2019). Here, NFE2L3 is linked to colonic neoplasm.